arginine and Apoplexy

arginine has been researched along with Apoplexy in 166 studies

Research

Studies (166)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	47 (28.31)	29.6817
2010's	95 (57.23)	24.3611
2020's	24 (14.46)	2.80

Authors

Authors	Studies
Boyle, K; Browne, E; Ni Cathain, D; Skehan, K	1
Du, Y; He, L; Liu, Q; Wang, H; Wang, J; Xu, J; Xu, X	1
Ahmed, M; Chiaramello, A; Gropman, A; Hao, L; Li, H; Navarro, R; Uittenbogaard, M	1
Blacker, DJ; Edwards, AB; Knuckey, NW; Meloni, BP	1
Blain, AP; Errington, L; Gorman, GS; McFarland, R; Ng, YS; Stefanetti, RJ	1
Alwis, I; Hofma, BR; Jackson, SP; Maclean, JAA; Samson, AL; Schoenwaelder, SM; Sturgeon, SA; Tomkins, AJ	1
Cernuda Morollón, E; Cortés Giménez-Coral, A; García Alonso, JI; González Gago, A; Lopez-Cancio, E; Prieto García, B; Rodríguez-González, P	1
Aitken, AV; Biancardi, VC; Chojnowski, K; Dańczyszyn, A; Gozdalski, J; Opiełka, M; Radziwon, J; Winklewski, PJ	1
Auriel, E; Barnea, R; Landau, YE; Mermelstein, M; Naftali, J; Peretz, S; Shelly, S	1
Sunada, Y	1
Ageev, SV; Jakovleva, AA; Kirik, OV; Kolpakova, ME; Korzhevskii, DE; Kukaliia, ON; Maistrenko, DN; Meshcheriakov, AA; Molchanov, OE; Murin, IV; Novikova, TA; Petrov, AV; Poliakova, LS; Semenov, KN; Sharoyko, VV; Vlasov, TD	1
Kim, J; Lee, DH; Sung, JH; Yi, HJ	1
Böger, RH; Choe, CU; Cordts, K; Gerloff, C; Grant, PJ; Lezius, S; Schwedhelm, E	1
Cifù, A; Curcio, F; Domenis, R; Fabris, M; Garbo, R; Giacomello, R; Gigli, GL; Janes, F; Nilo, A; Pessa, ME; Sanvilli, N; Valente, M	1
Catalin, B; Dumbrava, D; Gresita, A; Hermann, DM; Olaru, DG; Popa-Wagner, A; Surugiu, R	1
Bavendiek, U; Biber, S; Bode-Böger, SM; Gabriel, MM; Grosse, GM; Lichtinghagen, R; Martens-Lobenhoffer, J; Schuppner, R; Sieweke, JT; Weissenborn, K; Worthmann, H; Ziegler, NL	1
Arunachalam, P; Choe, CU; Gelderblom, M; Gerloff, C; Jensen, M; Magnus, T; Müller, C; Schwedhelm, E; Zeller, T	1
Chen, H; Pan, Y; Wang, Y; Yang, Y; Zhou, Z	1
Bocian, K; Fiszer, U; Korczak-Kowalska, G; Leńska-Mieciek, M	1
Song, T; Wang, S	1
Csuka, D; Garred, P; Illes, Z; Molnar, T; Nagy, L; Pusch, G	1
Boyle, G; Buchholz, H; Cantor, RS; Conway, J; Fynn-Thompson, F; Griffiths, E; Hawkins, B; Lorts, A; Lytrivi, ID; Machado, D; May, L; Niebler, RA; Rossano, J; Sutcliffe, DL; VanderPluym, CJ	1
Cai, D; Chen, S; He, J; Huang, P; Lai, Y; Liu, J; Sun, H; Zhou, L	1
Lee, JD; Taylor, SM; Woodruff, TM	1
Baba, Y; Higashino, M; Kimura, A; Sasaki, T; Sunaga, T; Tanioka, T; Watanabe, T	1
Choi, JS; Kim, G; Kim, M; Lee, J; Lee, M; Lee, Y	1
He, XY; Huang, P; Xu, M	1
Hou, X; Jin, C; Pan, C; Qi, D; Wang, X; Xue, J; Yang, Z	1
Arós, F; Clish, CB; Corella, D; Estruch, R; Fitó, M; Gómez-Gracia, E; Guasch-Ferré, M; Hruby, A; Hu, FB; Lapetra, J; Liang, L; Martínez-González, MA; Romaguera, D; Ros, E; Ruiz-Canela, M; Salas-Salvadó, J; Serra-Majem, L; Toledo, E; Wang, DD; Yu, E	1
Appleton, JP; Bath, PM; Krishnan, K	1
Barreto, AD; Cai, C; Ford, GA; Grotta, JC; Pedroza, C; Rahbar, MH; Shen, L; Tyson, J	1
Balabanski, A; Chia, N; Kleinig, T; Wai, K	1
Fischer, AM; Godier, A; Martin, AC; Mauge, L; Smadja, DM	1
Ahmad, S; Ducruet, AF; Larkin, TM; Lauver, MA; Zhao, XJ	1
Barreto, AD; Grotta, JC	1
Shah, NH	1
Bang, OY; Cho, YH; Chung, CS; Chung, JW; Kim, GM; Lee, KH; Moon, GJ; Oh, MJ	1
Falk, MJ; Ganetzky, RD	1
Carneiro, FS; Giachini, FR; Labazi, H; Lima, VV; Tostes, RC; Webb, RC; Wynne, BM	1
Amin-Hanjani, S; Becker, KJ; Bennett, DA; Bernhardt, J; Dichgans, M; Ford, GA; Goldstein, LB; Goyal, M; Greenberg, SM; Howard, G; Keller, E; Kidwell, CS; Olivot, JM; Pantoni, L; Pierot, L; Planas, AM; Reeves, M; Saposnik, G; Strbian, D; Thrift, A; Tymianski, M; Woo, D; Yenari, MA; Zorowitz, RD	1
Abe, S; Mitaki, S; Oguro, H; Onoda, K; Takayoshi, H; Yamaguchi, S	1
Ashida, S; Kojima, Y; Maezono, K; Nagakane, Y; Ogura, S; Tanaka, E; Yamamoto, Y	1
Cao, S; Chen, L; Yang, J	1
Abusoglu, S; Akbulut, D; Bal, C; Celik, HT; Ercan, M; Güzel, I; Mungan, S; Oguz, EF; Yilmaz, FM	1
Chong, RA; DeGiorgio, CM; Galati, A; Hovsepian, DA; Mazumder, R; Mishra, S; Yim, C	1
Cui, L; Pen, B; Wei, Y	1
Anderton, RS; Knuckey, NW; MacDougall, G; Mastaglia, FL; Meloni, BP	1
Barreto, AD; Berekashvili, K; Blackburn, S; Chen, PR; Dannenbaum, M; Grotta, JC; Misra, V; Shen, L; Soomro, J	1
Ageno, W; Agnelli, G; Chan, NC; De Caterina, R; Diener, HC; Hylek, E; Lip, GYH; Raskob, GE; Siegal, DM; Verheugt, FWA; Weitz, JI	1
Atzler, D; Böger, RH; Choe, CU; Cordts, K; Gerloff, C; Grant, PJ; Grzybowski, R; Hornig, S; Lezius, S; Lüneburg, N; Magnus, T; Neu, A; Schwedhelm, E; Thomalla, G	1
Csecsei, P; Farkas, N; Illés, Z; Kéki, S; Molnár, T; Nagy, L; Szapáry, L; Várnai, R	1
Ahmad, S; Bhatia, K; Ducruet, AF; Kindelin, A	1
Chen, S; Deb-Chatterji, M; Dong, Q; Kielstein, JT; Li, N; Weissenborn, K; Worthmann, H	1
Endo, M; Fukuda, N; Ikeda, K; Kobayashi, N; Matsumoto, K; Soma, M; Ueno, T	1
Bode-Böger, SM; Ehrenreich, H; Hecker, H; Joumaah, M; Kielstein, JT; Li, N; Lichtinghagen, R; Martens-Lobenhoffer, J; Weissenborn, K; Worthmann, H	1
Ally, A; Maher, TJ; Phattanarudee, S; Towiwat, P	1
Chang, SL; Chao, TF; Chen, SA; Hsieh, MH; Hu, YF; Lin, YJ; Lo, LW; Lu, TM; Tsao, HM; Tuan, TC	1
Michel, T	1
Atzler, D; Baldus, S; Benndorf, RA; Blankenberg, S; Böger, RH; Carter, AM; Choe, CU; De Deyn, PP; Gerloff, C; Grant, PJ; Heerschap, A; Isbrandt, D; Lackner, K; Lüneburg, N; Magnus, T; Marescau, B; Müller, C; Nabuurs, C; Ojeda, F; Schwedhelm, E; Simova, O; Stockebrand, M; Streichert, T; Wild, PS; Zeller, T	1
Fujimoto, Y; Iiyama, T; Kawanishi, Y; Kumagai, N; Okuhara, Y; Origasa, H; Takekawa, H; Yamaguchi, T	1
Chen, JL; Chen, W; Fan, RM; Han, C; Jiao, S; Li, G; Wang, CM; Xia, XP; Yao, ST; Zeng, YC	1
Balta, S; Korkmaz, H; Kurtoglu, E; Sincer, I	1
Kielstein, JT; Weissenborn, K; Worthmann, H	1
Adachi, H; Ishibashi, A; Yoshitake, Y	1
Abe, A; Inagaki, H; Katayama, Y; Kawada, T; Muraga, K; Nishiyama, Y; Otsuka, T; Ueda, M	1
Alizadeh, A; Gohari, G; Mahrooz, A	1
Abe, A; Katayama, Y; Muraga, K; Nishiyama, Y; Otsuka, T; Ueda, M	1
Chen, B; Lamb, J; Lei, IF; Lyden, P; Pereira, B; Rajput, P; Zhao, L	1
Kawamura, N; Sano, H; Sudo, A	1
Li, X; Ma, JP; Wang, JZ; Wang, L; Wu, CJ; Xia, XS	1
Biri, B; Feher, G; Illes, Z; Keki, S; Molnar, T; Nagy, L; Papp, V; Pusch, G; Szapary, L	1
Alasady, M; Chakrabarty, A; Lau, DH; Lim, HS; Roberts-Thomson, KC; Sanders, P; Schultz, C; Willoughby, SR; Worthley, MI; Young, GD	1
Anderssohn, M; Benjamin, EJ; Bernges, I; Blankenberg, S; Böger, RH; Carter, AM; Chen, MH; Erdmann, J; Fornage, M; Gieger, C; Glazer, NL; Grant, PJ; Heckbert, SR; Ikram, MA; Illig, T; Kittel, A; König, IR; König, J; Lackner, K; Lieb, W; Loley, C; Longstreth, WT; Lüneburg, N; Lunetta, KL; Maas, R; Meisinger, C; Munzel, T; Ojeda, FM; Psaty, BM; Schillert, A; Schunkert, H; Schwedhelm, E; Seshadri, S; Smith, N; Sticht, H; Sullivan, LM; Vasan, RS; Wang, TJ; Wichmann, HE; Wiggins, KL; Wild, PS; Xanthakis, V; Zeller, T; Ziegler, A	1
Borg, JY; Guegan-Massardier, E; Joly, B; Le Cam-Duchez, V; Menard, AL; Ozkul-Wermester, O; Triquenot-Bagan, A	1
Aoyama, Y; Fujita, T; Nishizawa, S; Ohta, S; Sakaki, S	1
Fan, D; Zhang, N; Zhang, Y	1
Anderton, RS; Brookes, LM; Clark, VW; Cross, JL; Edwards, AB; Hoffmann, K; Hopkins, RM; Knuckey, NW; Meloni, BP	1
Boitano, PD; Daley, JT; Lapchak, PA	1
Herson, PS; Shimizu, T; Sippel, TR; Strnad, F; Traystman, RJ; Waziri, A	1
Chowdhury, R; Chowdhury, S; Di Angelantonio, E; Freitag, DF; Gobin, R; Laukkanen, JA; Mayr, M; Willeit, P	1
Berkowitz, SD; Costin', J; Curnutte, JT; Gibson, CM; Hoffman, M; Kaminskas, E; Kowey, PR; Krucoff, MW; Levy, JH; Mintz, PD; Reilly, PA; Sager, PT; Sarich, TC; Seltzer, JH; Singer, DE; Stockbridge, N; Weitz, JI	1
Siddiq, I; Tein, I; Widjaja, E	1
Ran, X; Wang, DW; Zhang, Q	1
Haghikia, A; Hanff, E; Kayacelebi, AA; Maassen, N; Tsikas, D; Yanchev, GR	1
Fushimi, K; Horiguchi, H; Matsubara, T; Nakajima, S; Wada, T; Yahagi, N; Yasunaga, H	1
Manolov, VE; Petrova, JJ; Tzatchev, KN; Vasilev, VG; Zlatareva, DK	1
Blinova, TV; Bondareva, EA; Emanuel, VL; Emanuel, YV; Kharitonova, TV; Kholopova, IV; Lapin, SV; Lazareva, NM; Melnikova, EV; Shmonin, AA; Solovyeva, LN; Stolyarov, MS	1
Kobayashi, Y; Mano, T; Matsuo, K; Nishi, R	1
Babula, D; Gołąb, P; Hordyjewska, A; Horecka, A; Kurzepa, J; Szpetnar, M	1
Berki, T; Illes, Z; Keki, S; Molnar, T; Nagy, L; Pusch, G	1
Kaminskas, E; Reiffel, JA; Reilly, P; Sager, P; Sarich, T; Seltzer, J; Weitz, JI	1
Abe, T; Kitamura, M; Koga, Y; Povalko, N; Saiki, R; Ushijima, K; Yamashita, Y; Yatsuga, S	1
Finsterer, J; Wakil, SM	1
Kaatz, S; Milling, TJ	1
Bauersachs, J; Bavendiek, U; Bledau, N; Haghikia, A; Hanff, E; Kayacelebi, AA; Sonnenschein, K; Tsikas, D; Weissenborn, K; Widera, C; Yanchev, GR	1
Ay, H; Dalkara, T; Kirazli, S; Kocaefe, C; Moskowitz, MA; Ozcebe, O; Ozgüç, M; Qui, J; Topalkara, K; Yemisci, M	1
Castellanos, M; Castillo, J; Dávalos, A; García-Gil, M; Moldes, O; Pedraza, S; Pumar, JM; Serena, J; Silva, Y; Sobrino, T	1
Brouns, R; De Deyn, PP; Marescau, B; Possemiers, I; Sheorajpanday, R	1
Brandt, AS; Klotz, T; Mathers, MJ; Roth, S; Rundstedt, Fv; Sommer, F	1
Ajjan, R; Atzler, D; Böger, RH; Carter, AM; Grant, PJ; Maas, R; Schulze, F; Schwedhelm, E; von Holten, RA	1
Atzler, D; Böger, RH; Choe, CU; Gelderblom, M; Gerloff, C; Leypoldt, F; Magnus, T; Schwedhelm, E; Sydow, K; von Leitner, EC	1
Christenson, RH; Saenger, AK	1
Cavusoglu, E; Chopra, V; Eng, C; Frishman, WH; Marmur, JD; Pinsky, DJ; Poludasu, S; Ruwende, C; Yanamadala, S	1
Daneshtalab, N; Smeda, JS	1
Abe, A; Katayama, Y; Katsura, K; Nagayama, H; Nishiyama, Y; Otsuka, T; Ueda, M	2
Ding, H; Hui, R; Lu, Z; Shaffer, JR; Wang, DW; Wang, H; Wang, X; Wu, B; Yan, J	1
Bentley, P; Sharma, P	1
Bindoff, LA; Engelsen, BE; Ersland, L; Moen, G; Mørk, SJ; Neckelmann, G; Tzoulis, C; Viscomi, C; Zeviani, M	1
Kakimoto, N; Katayama, K; Koga, Y; Matsuishi, T; Nishioka, J; Povalko, N	1
Fukuda, M; Ishii, E; Morimoto, T; Shigemi, R; Suzuki, Y	1
Christopher, R; Mamatha, SN; Nagaraja, D; Philip, M	1
Fareed, J; Hoppensteadt, DA; Jeske, WP; Lewis, B; Walenga, JM	1
Ikeda, T; Ito, N; Maruyama, K; Nagane, M; Shiokawa, Y; Utagawa, A	1
Cho, TH; Derex, L; Kouamé-Assouan, AE; Lekoubou, A; Luauté, J; Nighoghossian, N	1
Bode-Böger, SM; Chen, S; Deb, M; Dong, Q; Goldbecker, A; Kielstein, JT; Li, N; Martens-Lobenhoffer, J; Tryc, AB; Weissenborn, K; Worthmann, H	1
Appleton, I; Clarkson, AN; Nair, SM; Rahman, RM; Sammut, IA; Sutherland, BA; Taurin, S	1
Chung, MY; Hsu, CP; Lin, CC; Lin, SJ; Lu, TM	1
Böger, RH; Lüneburg, N; Maas, R; Schwedhelm, E; Töpper, RF; von Holten, RA	1
Bedoya, G; Córdoba-Porras, A; López-Jaramillo, P; Rueda-Clausen, CF; Silva, FA; Villa, LA; Zarruk, JG	1
Alexandrov, AV; Balucani, C; Barlinn, K; Barreto, AD; Chen, Z; Demchuk, AM; Garami, Z; Gonzales, NR; Grotta, JC; Lee, J; Lyden, P; Martin-Schild, S; Mikulik, R; Pandurengan, R; Rahbar, MH; Savitz, SI; Shen, L; Sisson, A; Sugg, RM; Tsivgoulis, G; Wu, TC	1
Bath, PM	1
Kumagai, N; Nagao, T; Okuhara, Y; Origasa, H; Takekawa, H; Yamaguchi, T	1
Alasady, M; Brooks, AG; Gan, C; Kalman, JM; Kistler, PM; Lau, DH; Leong, DP; Lim, HS; Sanders, P; Schultz, C; Willoughby, SR; Worthley, MI; Young, GD	1
Arboleda-Velasquez, JF; Arcos-Burgos, M; Betensky, RA; Frosch, MP; Gutierrez, JE; Kosik, KS; Lebo, RV; Lopera, F; Lopez, E; Martinez De Arrieta, C; Medina, M; Restrepo, JC; Rivera, D; Sepulveda-Falla, D; Slaugenhaupt, SA; Vargas, S; Villegas, A	1
Iwata, M; Uchiyama, S; Yamazaki, M	1
Mizuno, Y; Noda, K; Tanaka, R; Urabe, T	1
Bath, FJ; Bath, PM; Leonardi-Bee, J; Willmot, M	1
Kawata, K; Matsuda, K; Negishi, M; Sekiguchi, F; Shimamur, K; Shinomiya, K; Sunano, S; Yamamoto, K	1
LaMonte, MP	1
Armengou, A; Castillo, J; Dávalos, A; Hurtado, O; Leira, R; Lizasoain, I; Moro, MA; Obón, M; Pascual, C	1
Haberl, RL; Wimmer, M; Zimmermann, C	1
Faraci, FM; Lentz, SR	1
Benke, KS; Damasceno, BP; Loscalzo, J; Panhuysen, CI; Voetsch, B	1
Böger, RH	1
Brown, PM; Hursting, MJ; LaMonte, MP; Nash, ML; Schultz, J; Wang, DZ; Woolfenden, AR	1
Nishio, I; Tsuda, K	1
LaMonte, MP; Stallmeyer, MJ	1
Kubota, M; Momoi-Yoshida, M; Mori, M; Sakakihara, Y; Yamagata, T	1
Laaksonen, R; Valkonen, VP	1
Ikeda, K; Noguchi, T; Sasaki, Y; Yamori, Y	1
Shinohara, Y	1
Brosnan, MJ; Dominiczak, AF; Graham, D; Hamilton, CA; Hanlon, N; Lee, WK; Mathers, J; McBride, MW; McLellan, LI; Miller, WH; Polke, JM	1
Akita, Y; Fujimoto, S; Koga, Y; Matsuishi, T; Nishioka, J; Povalko, N; Tanabe, Y; Yatsuga, S	1
Brattström, L; Brudin, L; Carlsson, M; Nilsson, I; Palmqvist, P; Teerlink, T; Wanby, P	1
Braunwald, E; DelMonte, T; Devlin, JJ; Dracopoli, NC; Hui, L; Iakoubova, OA; Kirchgessner, TG; Ranade, K; Sabatine, MS; Sacks, FM; Shaw, PM; Tsuchihashi, Z; Vishnupad, P; White, TJ	1
Bozzo, J; Escolar, G; Maragall, S	1
Aydin, M; Cetinkaya, Y; Gencer, M; Kara, I; Kilic, G; Orken, C; Ozbek, Z; Ozkok, E; Tireli, H	1
Akita, Y; Fukiyama, R; Ishii, M; Junko, N; Koga, Y; Matsuishi, T; Povalko, N; Yatsuga, S	1
Shima, K	1
Alexandrov, AV; Baraniuk, S; Garami, Z; Gonzales, NR; Grotta, JC; Matherne, DE; Mikulik, R; Moyé, LA; Pary, JK; Shaltoni, HM; Shaw, SG; Sugg, RM; Uchino, K	1
Carod-Artal, FJ	1
Haines, ST; Hursting, MJ; LaMonte, MP; Mikdashi, JA; Patterson, SL	1
Endo, H; Sansawa, H; Takahashi, M; Tsuchikura, S	1
Hosomi, N; Kobayashi, S; Kohno, M; Koziol, JA; Naya, T	1
Katayama, Y; Katsumata, T; Nishiyama, Y; Otori, T; Tanaka, N	1
Adali, O; Arinç, E; Bek, S; Can Demirdöğen, B; Demirkaya, S; Sanisoğlu, Y; Türkanoğlu, A; Vural, O	1
Bengtsson, C; Björkelund, C; Fogarty, J; Graham, I; Leong, T; Lissner, L; Thelle, D; Ward, D; Zylberstein, D	1
Chevalier, A; Nutescu, EA; Shapiro, NL	1
Katayama, Y; Otsubo, K	1
Bath, FJ; Bath, PM; Butterworth, RJ	1
Bode, C; Darius, H; Diehm, C; Encke, A; Gulba, DC; Haas, S; Hacke, W; Puhl, W; Quante, M; Riess, H; Scharf, R; Schellong, S; Schrör, T; Schulte, KL; Tebbe, U; Van Aken, H	1
Lee, SC; Yoo, JH	1
Berens, KL; Brown, PM; Chopp, M; Lu, M; Morris, DC; Zhang, L; Zhang, ZG	1
Akita, Y; Fukiyama, R; Ishibashi, M; Koga, Y; Matsuishi, T; Ueki, I; Yatsuga, S	1
Chen, SH; Cheung, RT; Fung, PC	1

Reviews

32 review(s) available for arginine and Apoplexy

Article	Year
l-Arginine in Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like Episodes: A Systematic Review. Neurology, 2022, 06-07, Volume: 98, Issue:23 Topics: Acidosis, Lactic; Anticonvulsants; Arginine; Humans; Mitochondrial Diseases; Mitochondrial Encephalomyopathies; Retrospective Studies; Stroke	2022
The Role of Arginine-Vasopressin in Stroke and the Potential Use of Arginine-Vasopressin Type 1 Receptor Antagonists in Stroke Therapy: A Narrative Review. International journal of molecular sciences, 2023, Jan-20, Volume: 24, Issue:3 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine; Arginine Vasopressin; Glycopeptides; Nervous System Diseases; Stroke; Vasopressins	2023
Mitochondrial DNA 10158T>C mutation in a patient with mitochondrial encephalomyopathy with lactic acidosis, and stroke-like episodes syndrome: A case-report and literature review (CARE-complaint). Medicine, 2020, Jun-12, Volume: 99, Issue:24 Topics: Acidosis, Lactic; Administration, Oral; Arginine; Awareness; Brain; DNA, Mitochondrial; Female; Humans; Magnetic Resonance Imaging; MELAS Syndrome; Micronutrients; Mitochondrial Encephalomyopathies; Muscle, Skeletal; Mutation; Stroke; Succinate Dehydrogenase; Ubiquinone; Young Adult	2020
Effects of argatroban therapy for stroke patients: A meta-analysis. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2021, Volume: 90 Topics: Arginine; Humans; Pipecolic Acids; Platelet Aggregation Inhibitors; Stroke; Sulfonamides	2021
Nitric oxide donors (nitrates), L-arginine, or nitric oxide synthase inhibitors for acute stroke. The Cochrane database of systematic reviews, 2017, 04-21, Volume: 4 Topics: Acute Disease; Arginine; Brain Ischemia; Enzyme Inhibitors; Headache; Humans; Nitric Oxide Donors; Nitric Oxide Synthase; Nitroglycerin; Quality of Life; Randomized Controlled Trials as Topic; Stroke	2017
[State of the art: Direct oral anticoagulants and transfusion]. Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, 2017, Volume: 24, Issue:3 Topics: Administration, Oral; Antibodies, Monoclonal, Humanized; Antidotes; Antithrombins; Arginine; Blood Coagulation Factors; Blood Transfusion; Dabigatran; Factor Xa; Factor Xa Inhibitors; Hemorrhage; Hemostatics; Humans; Piperazines; Pyrazoles; Pyridones; Recombinant Proteins; Rivaroxaban; Stroke; Thrombophilia	2017
Advances in Stroke 2017. Stroke, 2018, Volume: 49, Issue:5 Topics: Antibodies, Monoclonal, Humanized; Anticoagulants; Antidotes; Antihypertensive Agents; Arginine; Delivery of Health Care; Factor Xa; Health Policy; Humans; Hypertension; Intracranial Hemorrhages; Outcome Assessment, Health Care; Piperazines; Recombinant Proteins; Stroke; Stroke Rehabilitation; Thrombectomy; Thrombolytic Therapy	2018
Mitochondria and neuroprotection in stroke: Cationic arginine-rich peptides (CARPs) as a novel class of mitochondria-targeted neuroprotective therapeutics. Neurobiology of disease, 2019, Volume: 121 Topics: Animals; Arginine; Brain Ischemia; Humans; Mitochondria; Neuroprotective Agents; Peptides; Stroke; Treatment Outcome	2019
The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V-Special Situations. Thrombosis and haemostasis, 2019, Volume: 119, Issue:1 Topics: Administration, Oral; Antibodies, Monoclonal, Humanized; Anticoagulants; Arginine; Atrial Fibrillation; Benzamides; Biomarkers; Blood Coagulation; Clinical Trials as Topic; Dabigatran; Drug Administration Schedule; Factor Xa; Heart Diseases; Humans; Piperazines; Pyrazoles; Pyridines; Pyridones; Recombinant Proteins; Risk; Rivaroxaban; Stroke; Thiazoles; Thrombin; Venous Thromboembolism; Vitamin K; Warfarin	2019
The Role of Complement C3a Receptor in Stroke. Neuromolecular medicine, 2019, Volume: 21, Issue:4 Topics: Animals; Arginine; Benzhydryl Compounds; Blood-Brain Barrier; Complement Activation; Complement C3a; Complement Inactivating Agents; Disease Models, Animal; Humans; Immunity, Innate; Mice; Mice, Knockout; Neuroimmunomodulation; Neuroprotective Agents; Receptors, Complement; Stroke; Translational Research, Biomedical	2019
Asymmetric dimethyarginine as marker and mediator in ischemic stroke. International journal of molecular sciences, 2012, Nov-28, Volume: 13, Issue:12 Topics: Animals; Arginine; Biomarkers; Brain Ischemia; Cerebrovascular Circulation; Enzyme Inhibitors; Humans; Methylation; Nitric Oxide Synthase; Oxidative Stress; Protein Processing, Post-Translational; Stroke	2012
Asymmetric dimethylarginine and cardiovascular risk: systematic review and meta-analysis of 22 prospective studies. Journal of the American Heart Association, 2015, May-28, Volume: 4, Issue:6 Topics: Arginine; Cardiovascular Diseases; Humans; Odds Ratio; Prospective Studies; Stroke	2015
NOAC monitoring, reversal agents, and post-approval safety and effectiveness evaluation: A cardiac safety research consortium think tank. American heart journal, 2016, Volume: 177 Topics: Antibodies, Monoclonal, Humanized; Antidotes; Antithrombins; Arginine; Atrial Fibrillation; Congresses as Topic; Dabigatran; Drug Monitoring; Factor Xa; Factor Xa Inhibitors; Humans; Partial Thromboplastin Time; Piperazines; Product Surveillance, Postmarketing; Pyrazoles; Pyridines; Pyridones; Recombinant Proteins; Rivaroxaban; Stroke; Thiazoles; Thrombin Time; Venous Thromboembolism	2016
Stroke-like episodes, peri-episodic seizures, and MELAS mutations. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 2016, Volume: 20, Issue:6 Topics: Aged; Anticonvulsants; Arginine; Diet, Ketogenic; DNA, Mitochondrial; Female; Humans; Male; MELAS Syndrome; Middle Aged; Mutation; Seizures; Stroke	2016
Preclinical and Clinical Data for Factor Xa and "Universal" Reversal Agents. The American journal of medicine, 2016, Volume: 129, Issue:11S Topics: Animals; Antidotes; Arginine; Atrial Fibrillation; Factor Xa; Factor Xa Inhibitors; Hemorrhage; Humans; Piperazines; Pyrazoles; Pyridones; Recombinant Proteins; Rivaroxaban; Stroke; Thromboembolism	2016
[Metabolism of nitric oxide (NO) and arginine: significance for male health]. Aktuelle Urologie, 2009, Volume: 40, Issue:4 Topics: Arginine; Atherosclerosis; Diabetes Mellitus; Endothelium, Vascular; Flavonoids; Humans; Impotence, Vasculogenic; Infertility, Male; Male; Male Urogenital Diseases; Neurodegenerative Diseases; Nitric Oxide; Nitric Oxide Synthase; Plant Extracts; Platelet Aggregation Inhibitors; Sepsis; Stroke; Vasodilation	2009
Stroke biomarkers: progress and challenges for diagnosis, prognosis, differentiation, and treatment. Clinical chemistry, 2010, Volume: 56, Issue:1 Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Arginine; Biomarkers; Diffusion Magnetic Resonance Imaging; Glial Fibrillary Acidic Protein; Humans; Matrix Metalloproteinase 9; Nerve Growth Factors; Prognosis; Receptors, N-Methyl-D-Aspartate; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Stroke; Tomography, X-Ray Computed	2010
MELAS and L-arginine therapy: pathophysiology of stroke-like episodes. Annals of the New York Academy of Sciences, 2010, Volume: 1201 Topics: Arginine; Brain; Endothelium; Glucose; Homeostasis; Humans; Magnetic Resonance Imaging; MELAS Syndrome; Mitochondria; Mitochondrial Diseases; Models, Biological; Muscles; Oxygen; Stroke; Tomography, Emission-Computed, Single-Photon	2010
Pharmacology of argatroban. Expert review of hematology, 2010, Volume: 3, Issue:5 Topics: Acute Coronary Syndrome; Antithrombins; Arginine; European Union; Female; Heparin; Humans; Isomerism; Japan; Male; Peptidomimetics; Pipecolic Acids; Stroke; Sulfonamides; Thrombin; Thrombocytopenia; Thrombosis; United States	2010
[Strategy for circulatory disturbance]. Rinsho shinkeigaku = Clinical neurology, 2001, Volume: 41, Issue:12 Topics: Abciximab; Antibodies, Monoclonal; Anticoagulants; Arginine; Aspirin; Clinical Trials as Topic; Heparin; Humans; Immunoglobulin Fab Fragments; Meta-Analysis as Topic; Pipecolic Acids; Platelet Aggregation Inhibitors; Streptokinase; Stroke; Sulfonamides; Thrombolytic Therapy; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator	2001
Nitric oxide donors (nitrates), L-arginine, or nitric oxide synthase inhibitors for acute stroke. The Cochrane database of systematic reviews, 2002, Issue:4 Topics: Arginine; Brain Ischemia; Enzyme Inhibitors; Humans; Nitric Oxide Donors; Nitric Oxide Synthase; Stroke	2002
Argatroban in thrombotic stroke. Pathophysiology of haemostasis and thrombosis, 2002, Volume: 32 Suppl 3 Topics: Animals; Anticoagulants; Arginine; Brain Ischemia; Collateral Circulation; Humans; Pipecolic Acids; Stroke; Sulfonamides; Thrombin; Thrombosis	2002
[Asymmetrical methylarginine (ADMA) as a cardiovascular risk factor: epidemiological and prospective data]. Deutsche medizinische Wochenschrift (1946), 2004, Apr-08, Volume: 129, Issue:15 Topics: Adult; Aged; Aged, 80 and over; Animals; Arginine; Arteriosclerosis; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Cells, Cultured; Child; Coronary Disease; Diabetes Mellitus, Type 2; Disease Models, Animal; Endothelial Cells; Enzyme-Linked Immunosorbent Assay; Female; Free Radicals; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Multicenter Studies as Topic; Multivariate Analysis; Nitric Oxide Synthase; Oxidative Stress; Pre-Eclampsia; Pregnancy; Prospective Studies; Rabbits; Regression Analysis; Renal Dialysis; Risk Factors; Stroke	2004
Asymmetric dimethylarginine (ADMA) and acute vascular events. Clinica chimica acta; international journal of clinical chemistry, 2004, Volume: 348, Issue:1-2 Topics: Acute Disease; Angina Pectoris; Arginine; Cardiovascular Diseases; Humans; Myocardial Infarction; Stroke	2004
[Clinical guidelines for stroke]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2004, Nov-10, Volume: 93, Issue:11 Topics: Anticoagulants; Antipyrine; Arginine; Aspirin; Brain Edema; Edaravone; Fibrinolytic Agents; Free Radical Scavengers; Glycerol; Humans; Hyperlipidemias; Hypertension; Japan; Methacrylates; Pipecolic Acids; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk Factors; Stroke; Sulfonamides; Thrombolytic Therapy; Time Factors; Warfarin	2004
Argatroban: a direct thrombin inhibitor with reliable and predictable anticoagulant actions. Drugs of today (Barcelona, Spain : 1998), 2006, Volume: 42, Issue:4 Topics: Animals; Anticoagulants; Arginine; Blood Coagulation; Drug Monitoring; Humans; Intracranial Thrombosis; Pipecolic Acids; Randomized Controlled Trials as Topic; Stroke; Sulfonamides; Thrombin; Thrombocytopenia	2006
[Advanced medical therapy in patients with acute ischemic stroke]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2006, Volume: 127, Issue:6 Topics: Administration, Oral; Anticoagulants; Antipyrine; Arginine; Aspirin; Drug Design; Edaravone; Fibrinolytic Agents; Genomics; Heparin; Humans; Infusions, Intravenous; Pipecolic Acids; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Stroke; Sulfonamides; Time Factors; Tissue Plasminogen Activator	2006
Anticoagulation strategies for treatment of ischemic stroke and antiphospholipid syndrome: case report and review of the literature. Pharmacotherapy, 2006, Volume: 26, Issue:10 Topics: Anticoagulants; Antiphospholipid Syndrome; Arginine; Azathioprine; Brain Ischemia; Dexamethasone; Humans; Male; Middle Aged; Pipecolic Acids; Stroke; Sulfonamides; Warfarin	2006
New anticoagulant agents: direct thrombin inhibitors. Cardiology clinics, 2008, Volume: 26, Issue:2 Topics: Anticoagulants; Arginine; Atrial Fibrillation; Benzimidazoles; Dabigatran; Fibrinolytic Agents; Half-Life; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Pyridines; Recombinant Proteins; Stroke; Sulfonamides; Thrombin	2008
[Therapeutic time window in ischemic stroke]. Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2000, Volume: 67, Issue:2 Topics: Animals; Arginine; Drug Therapy, Combination; Heparin; Humans; Methacrylates; Pipecolic Acids; Recombinant Proteins; Streptokinase; Stroke; Sulfonamides; Time Factors; Tissue Plasminogen Activator	2000
Nitric oxide donors (nitrates), L-arginine, or nitric oxide synthase inhibitors for acute ischaemic stroke. The Cochrane database of systematic reviews, 2000, Issue:2 Topics: Arginine; Brain Ischemia; Enzyme Inhibitors; Humans; Nitric Oxide Donors; Nitric Oxide Synthase; Stroke	2000
Anticoagulation: the present and future. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2001, Volume: 7, Issue:3 Topics: Administration, Oral; Amino Acid Chloromethyl Ketones; Anticoagulants; Arginine; Azetidines; Benzylamines; Binding Sites; Biological Availability; Blood Coagulation; Comorbidity; Coumarins; Drug Design; Embolism; Female; Forecasting; Glycine; Guanidines; Heart Diseases; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Hirudin Therapy; Humans; Neoplasms; Pipecolic Acids; Pregnancy; Pregnancy Complications, Hematologic; Prodrugs; Safety; Serine; Stroke; Sulfonamides; Thrombin; Thrombophilia; Thrombosis	2001

Trials

17 trial(s) available for arginine and Apoplexy

Article	Year
Randomized trial of argatroban plus recombinant tissue-type plasminogen activator for acute ischemic stroke (ARAIS): Rationale and design. American heart journal, 2020, Volume: 225 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antithrombins; Arginine; Drug Therapy, Combination; Female; Humans; Intention to Treat Analysis; Male; Middle Aged; Pipecolic Acids; Single-Blind Method; Stroke; Sulfonamides; Tissue Plasminogen Activator; Young Adult	2020
Effect of Argatroban Injection on Clinical Efficacy in Patients with Acute Cerebral Infarction: Preliminary Findings. European neurology, 2021, Volume: 84, Issue:1 Topics: Activities of Daily Living; Arginine; Cerebral Infarction; Humans; Pipecolic Acids; Stroke; Sulfonamides; Treatment Outcome	2021
Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke). Stroke, 2017, Volume: 48, Issue:6 Topics: Aged; Aged, 80 and over; Antithrombins; Arginine; Brain Ischemia; Cerebral Hemorrhage; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Pipecolic Acids; Severity of Illness Index; Stroke; Sulfonamides; Tissue Plasminogen Activator	2017
Asymmetric dimethylarginine in response to recombinant tissue-type plasminogen activator and erythropoietin in acute stroke. Stroke, 2013, Volume: 44, Issue:8 Topics: Acute Disease; Aged; Aged, 80 and over; Arginine; Double-Blind Method; Drug Therapy, Combination; Erythropoietin; Female; Humans; Male; Middle Aged; Severity of Illness Index; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome	2013
Effects of smoking on outcomes after acute atherothrombotic stroke in Japanese men. Journal of the neurological sciences, 2013, Dec-15, Volume: 335, Issue:1-2 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antipyrine; Antithrombins; Arginine; Asian People; Body Temperature; Case-Control Studies; Edaravone; Humans; Logistic Models; Male; Pipecolic Acids; Retrospective Studies; Severity of Illness Index; Smoking; Stroke; Sulfonamides; Treatment Outcome; Young Adult	2013
Supplementation of folic acid and vitamin B₁₂ reduces plasma levels of asymmetric dimethylarginine in patients with acute ischemic stroke. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2014, Volume: 21, Issue:9 Topics: Aged; Arginine; Blood Chemical Analysis; Brain Ischemia; Dietary Supplements; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Stroke; Time Factors; Treatment Outcome; Vitamin B 12	2014
[Argatroban, Aspirin, and Clopidogrel Combination Therapy for Acute Penetrating Artery Infarction: A Pilot Study]. Brain and nerve = Shinkei kenkyu no shinpo, 2016, Volume: 68, Issue:2 Topics: Acute Disease; Aged; Arginine; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Humans; Infarction; Male; Middle Aged; Pilot Projects; Pipecolic Acids; Platelet Aggregation Inhibitors; Prospective Studies; Stroke; Sulfonamides; Ticlopidine; Treatment Outcome	2016
Actylise treatment does not influence nitric oxide metabolites serum level. Pharmacological reports : PR, 2016, Volume: 68, Issue:3 Topics: Aged; Arginine; Citrulline; Female; Humans; Male; Nitric Oxide; Stroke; Tissue Plasminogen Activator	2016
Statin potentiates human platelet eNOS activity without enhancing eNOS mRNA and protein levels. Cerebrovascular diseases (Basel, Switzerland), 2008, Volume: 26, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Arginine; Bleeding Time; Blood Platelets; Brain Ischemia; Enzyme Inhibitors; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase Type III; Ornithine; Platelet Aggregation; Pravastatin; RNA, Messenger; Stroke; Treatment Outcome	2008
Statin treatment decreased serum asymmetric dimethylarginine (ADMA) levels in ischemic stroke patients. Journal of atherosclerosis and thrombosis, 2011, Volume: 18, Issue:2 Topics: Aged; Aged, 80 and over; Arginine; Atherosclerosis; Atorvastatin; Brain Ischemia; Cholesterol, LDL; Fatty Acids, Monounsaturated; Female; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Linear Models; Male; Middle Aged; Pravastatin; Prospective Studies; Pyrroles; Quinolines; Stroke	2011
Prognostic significance of smoking in patients with acute ischemic stroke within 3 months of onset. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2013, Volume: 22, Issue:6 Topics: Aged; Aged, 80 and over; Antipyrine; Arginine; Brain Ischemia; Chi-Square Distribution; Disability Evaluation; Drug Therapy, Combination; Edaravone; Female; Fibrinolytic Agents; Humans; Japan; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Pipecolic Acids; Recovery of Function; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Stroke; Sulfonamides; Time Factors; Treatment Outcome	2013
Anticoagulant therapy with a selective thrombin inhibitor for acute cerebral infarction: usefulness of coagulation markers for evaluation of efficacy. Journal of thrombosis and thrombolysis, 2002, Volume: 13, Issue:3 Topics: Acute Disease; Aged; Anticoagulants; Antithrombins; Arginine; Biomarkers; Blood Coagulation; Blood Coagulation Tests; Blood Proteins; Cerebral Infarction; Embolism; Female; Hemorrhage; Humans; Male; Middle Aged; Pipecolic Acids; Stroke; Sulfonamides; Thrombosis; Treatment Outcome	2002
L-arginine-mediated vasoreactivity in patients with a risk of stroke. Cerebrovascular diseases (Basel, Switzerland), 2004, Volume: 17, Issue:2-3 Topics: Aged; Arginine; Blood Flow Velocity; Carotid Artery, Common; Cerebrovascular Circulation; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Predictive Value of Tests; Risk Factors; Stroke; Ultrasonography, Doppler, Transcranial	2004
Argatroban anticoagulation in patients with acute ischemic stroke (ARGIS-1): a randomized, placebo-controlled safety study. Stroke, 2004, Volume: 35, Issue:7 Topics: Aged; Anticoagulants; Arginine; Double-Blind Method; Drug Administration Schedule; Female; Humans; Intracranial Hemorrhages; Male; Middle Aged; Partial Thromboplastin Time; Pipecolic Acids; Stroke; Sulfonamides; Survival Analysis	2004
L-arginine improves the symptoms of strokelike episodes in MELAS. Neurology, 2005, Feb-22, Volume: 64, Issue:4 Topics: Administration, Oral; Adolescent; Adult; Amino Acids; Arginine; Cerebral Arteries; Child; Child, Preschool; Cholesterol; Cyclic GMP; Female; Headache; Humans; Male; MELAS Syndrome; Nitric Oxide; Paresis; Seizures; Stroke; Treatment Outcome; Vasodilation; Vision Disorders; Vomiting	2005
Endothelial dysfunction in MELAS improved by l-arginine supplementation. Neurology, 2006, Jun-13, Volume: 66, Issue:11 Topics: Administration, Oral; Adolescent; Adult; Arginine; Blood Flow Velocity; Cerebrovascular Circulation; Child; Dietary Supplements; Endothelium, Vascular; Female; Humans; Male; MELAS Syndrome; Middle Aged; Stroke; Vasodilator Agents	2006
Argatroban tPA stroke study: study design and results in the first treated cohort. Archives of neurology, 2006, Volume: 63, Issue:8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arginine; Cerebral Hemorrhage; Cohort Studies; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pipecolic Acids; Prospective Studies; Recombinant Proteins; Research Design; Stroke; Sulfonamides; Tissue Plasminogen Activator; Treatment Outcome	2006

Other Studies

117 other study(ies) available for arginine and Apoplexy

Article	Year
MELAS syndrome: an acute stroke-like episode complicated by renal tubular acidosis. BMJ case reports, 2021, Nov-02, Volume: 14, Issue:11 Topics: Acidosis, Renal Tubular; Arginine; Humans; MELAS Syndrome; Stroke	2021
Dual Antiplatelet Therapy Plus Argatroban Prevents Early Neurological Deterioration in Branch Atherosclerosis Disease. Stroke, 2022, Volume: 53, Issue:1 Topics: Arginine; Aspirin; Atherosclerosis; Brain Ischemia; Clopidogrel; Humans; Pipecolic Acids; Platelet Aggregation Inhibitors; Stroke; Sulfonamides; Ticlopidine	2022
Integrated proteomic and metabolomic analyses of the mitochondrial neurodegenerative disease MELAS. Molecular omics, 2022, 03-28, Volume: 18, Issue:3 Topics: Arginine; Chromatography, Liquid; Humans; MELAS Syndrome; Metabolomics; Neurodegenerative Diseases; Proteomics; Stroke; Tandem Mass Spectrometry	2022
Impact of poly-arginine peptides R18D and R18 on alteplase and tenecteplase thrombolysis in vitro, and neuroprotective stability to proteolysis. Journal of thrombosis and thrombolysis, 2022, Volume: 54, Issue:1 Topics: Arginine; Brain Ischemia; Fibrinolytic Agents; Humans; Peptides; Proteolysis; Stroke; Tenecteplase; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator	2022
Development of a carotid artery thrombolysis stroke model in mice. Blood advances, 2022, 09-27, Volume: 6, Issue:18 Topics: Animals; Anticoagulants; Antithrombins; Arginine; Brain Ischemia; Carotid Artery, Common; Fibrinolytic Agents; Infarction, Middle Cerebral Artery; Ischemic Stroke; Mice; Pipecolic Acids; Stroke; Sulfonamides; Thromboembolism; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome	2022
Comparison between one and two-dimensional liquid chromatographic approaches for the determination of plasmatic stroke biomarkers by isotope dilution and tandem mass spectrometry. The Analyst, 2023, Jan-31, Volume: 148, Issue:3 Topics: Arginine; Biomarkers; Chromatography, Liquid; Humans; Isotopes; Reproducibility of Results; Stroke; Tandem Mass Spectrometry	2023
Clinical score for early diagnosis and treatment of stroke-like episodes in MELAS syndrome. Acta neurologica Belgica, 2023, Volume: 123, Issue:3 Topics: Arginine; Early Diagnosis; Humans; Ischemic Stroke; MELAS Syndrome; Retrospective Studies; Seizures; Stroke	2023
[Therapeutics for Mitochondrial Encephalomyopathy]. Brain and nerve = Shinkei kenkyu no shinpo, 2023, Volume: 75, Issue:5 Topics: Arginine; Humans; MELAS Syndrome; Mitochondria; Stroke; Taurine	2023
C Nanomedicine : nanotechnology, biology, and medicine, 2023, Volume: 53 Topics: Antioxidants; Arginine; Fullerenes; Humans; Ischemia; Ischemic Stroke; Nanostructures; Stroke; Water	2023
Safety and Feasibility of Using Argatroban Immediately After Mechanical Thrombectomy for Large Artery Occlusion. World neurosurgery, 2019, Volume: 132 Topics: Adult; Aged; Arginine; Cerebral Arterial Diseases; Female; Humans; Male; Mechanical Thrombolysis; Middle Aged; Pipecolic Acids; Platelet Aggregation Inhibitors; Retrospective Studies; Stroke; Sulfonamides	2019
Low homoarginine/SDMA ratio is associated with poor short- and long-term outcome after stroke in two prospective studies. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2020, Volume: 41, Issue:1 Topics: Arginine; Biomarkers; Cohort Studies; Homoarginine; Humans; Prospective Studies; Stroke; Survival Rate; Treatment Outcome	2020
ADMA as a possible marker of endothelial damage. A study in young asymptomatic patients with cerebral small vessel disease. Scientific reports, 2019, 10-02, Volume: 9, Issue:1 Topics: Adult; Aged; Aging; Arginine; Biomarkers; Brain; Cerebral Small Vessel Diseases; Cognitive Dysfunction; Endothelial Cells; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Stroke	2019
Intracortical Administration of the Complement C3 Receptor Antagonist Trifluoroacetate Modulates Microglia Reaction after Brain Injury. Neural plasticity, 2019, Volume: 2019 Topics: Animals; Arginine; Benzhydryl Compounds; Disease Models, Animal; Mice; Microglia; Neurons; Phagocytosis; Receptors, Complement; Recovery of Function; Stroke; Trifluoroacetic Acid	2019
Markers of endothelial pathology to support detection of atrial fibrillation in embolic stroke of undetermined source. Scientific reports, 2019, 12-19, Volume: 9, Issue:1 Topics: Aged; Aged, 80 and over; Arginine; Atrial Fibrillation; Biomarkers; Carotid Intima-Media Thickness; Electrocardiography; Embolism; Endothelium; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Risk Factors; ROC Curve; Statistics, Nonparametric; Stroke	2019
Homoarginine- and Creatine-Dependent Gene Regulation in Murine Brains with l-Arginine:Glycine Amidinotransferase Deficiency. International journal of molecular sciences, 2020, Mar-09, Volume: 21, Issue:5 Topics: Amidinotransferases; Amino Acid Metabolism, Inborn Errors; Animals; Arginine; Brain; Creatine; Developmental Disabilities; Gene Expression Regulation; Glycine; Homoarginine; Intellectual Disability; Mice; Mice, Inbred C57BL; Speech Disorders; Stroke	2020
Pentosidine, advanced glycation end product, in acute ischaemic stroke patients with and without atrial rhythm disturbances. Neurologia i neurochirurgia polska, 2020, Volume: 54, Issue:4 Topics: Arginine; Atrial Fibrillation; Brain Ischemia; Carotid Intima-Media Thickness; Humans; Lysine; Risk Factors; Stroke	2020
Associations between serum L-arginine and ficolins in the early phase of acute ischemic stroke - A pilot study. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2020, Volume: 29, Issue:8 Topics: Aged; Aged, 80 and over; Arginine; Biomarkers; Brain Ischemia; Communicable Diseases; Female; Ficolins; Humans; Lectins; Male; Middle Aged; Pilot Projects; Predictive Value of Tests; Prognosis; Risk Factors; Stroke; Time Factors	2020
Utilization and Outcomes of Children Treated with Direct Thrombin Inhibitors on Paracorporeal Ventricular Assist Device Support. ASAIO journal (American Society for Artificial Internal Organs : 1992), 2020, Volume: 66, Issue:8 Topics: Adolescent; Antithrombins; Arginine; Child; Child, Preschool; Female; Heart-Assist Devices; Hemorrhage; Hirudins; Humans; Infant; Male; North America; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Retrospective Studies; Stroke; Sulfonamides; Thrombosis; Treatment Outcome	2020
Early and long-term outcomes of argatroban use in patients with acute noncardioembolic stroke. Clinical neurology and neurosurgery, 2020, Volume: 198 Topics: Aged; Arginine; Brain Ischemia; Endovascular Procedures; Female; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Aggregation Inhibitors; Retrospective Studies; Stroke; Sulfonamides; Treatment Outcome	2020
Is the C3a receptor antagonist SB290157 a useful pharmacological tool? British journal of pharmacology, 2020, Volume: 177, Issue:24 Topics: Animals; Arginine; Benzhydryl Compounds; Mice; Stroke; Thrombolytic Therapy	2020
[Examination of the Relationship between Worse Symptom and Differences Route during Administration of Argatroban in Acute Ischemic Stroke Patients]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2020, Volume: 140, Issue:11 Topics: Administration, Intravenous; Aged; Aged, 80 and over; Arginine; Drug Administration Routes; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Patient Outcome Assessment; Pipecolic Acids; Retrospective Studies; Safety; Stroke; Sulfonamides; Symptom Flare Up	2020
Brain gene delivery using histidine and arginine-modified dendrimers for ischemic stroke therapy. Journal of controlled release : official journal of the Controlled Release Society, 2021, 02-10, Volume: 330 Topics: Animals; Arginine; Brain; Brain Ischemia; Dendrimers; Gene Transfer Techniques; Genetic Therapy; Histidine; Ischemic Stroke; Plasmids; Stroke; Transfection	2021
Plasma Arginine/Asymmetric Dimethylarginine Ratio and Incidence of Cardiovascular Events: A Case-Cohort Study. The Journal of clinical endocrinology and metabolism, 2017, 06-01, Volume: 102, Issue:6 Topics: Aged; Arginine; Cardiovascular Diseases; Case-Control Studies; Chromatography, Liquid; Citrulline; Cohort Studies; Female; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; omega-N-Methylarginine; Ornithine; Proportional Hazards Models; Prospective Studies; Risk Factors; Stroke; Tandem Mass Spectrometry	2017
Reversible hemispheric hypoperfusion in two cases of SMART syndrome. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2017, Volume: 43 Topics: Aged; Arginine; Cerebrovascular Circulation; Cerebrovascular Disorders; Cranial Irradiation; Humans; Male; Middle Aged; Migraine Disorders; Radiation Injuries; Stroke; Syndrome	2017
Tissue plasminogen activator mediates deleterious complement cascade activation in stroke. PloS one, 2017, Volume: 12, Issue:7 Topics: Animals; Arginine; Benzhydryl Compounds; Brain; Brain Edema; Cell Death; Cells, Cultured; Complement C3; Endothelial Cells; Fibrinolysin; Hemoglobins; Hemorrhage; Humans; Immunohistochemistry; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Inbred C57BL; Stroke; Tissue Plasminogen Activator	2017
Response by Barreto and Grotta to Letter Regarding Article, "Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke)". Stroke, 2017, Volume: 48, Issue:9 Topics: Arginine; Brain Ischemia; Fibrinolytic Agents; Humans; Pipecolic Acids; Recombinant Proteins; Stroke; Sulfonamides; Tissue Plasminogen Activator; Treatment Outcome	2017
Letter by Shah Regarding Article, "Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke)". Stroke, 2017, Volume: 48, Issue:9 Topics: Arginine; Brain Ischemia; Fibrinolytic Agents; Humans; Pipecolic Acids; Recombinant Proteins; Stroke; Sulfonamides; Tissue Plasminogen Activator; Treatment Outcome	2017
Distinct Roles of Endothelial Dysfunction and Inflammation in Intracranial Atherosclerotic Stroke. European neurology, 2017, Volume: 77, Issue:3-4 Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Aged; Arginine; Biomarkers; Endothelium; Female; Humans; Inflammation; Intracranial Arteriosclerosis; Male; Middle Aged; Stroke	2017
8-year retrospective analysis of intravenous arginine therapy for acute metabolic strokes in pediatric mitochondrial disease. Molecular genetics and metabolism, 2018, Volume: 123, Issue:3 Topics: Adolescent; Adult; Arginine; Brain; Child; Child, Preschool; Citrulline; DNA, Mitochondrial; Female; Humans; Infant; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Mitochondria; Mitochondrial Diseases; Nitric Oxide; Prospective Studies; Retrospective Studies; Stroke; Treatment Outcome; Young Adult	2018
Mesenteric arteries from stroke-prone spontaneously hypertensive rats exhibit an increase in nitric-oxide-dependent vasorelaxation. Canadian journal of physiology and pharmacology, 2018, Volume: 96, Issue:8 Topics: Acetylcholine; Animals; Arginase; Arginine; Blood Pressure; Endothelium, Vascular; Enzyme Activation; Male; Mesenteric Arteries; Neurons; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Proto-Oncogene Proteins c-akt; Rats, Inbred SHR; Stroke; Substrate Specificity; Systole; Vasodilation	2018
Retrospective Analysis of Argatroban in 353 Patients with Acute Noncardioembolic Stroke. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2018, Volume: 27, Issue:8 Topics: Aged; Aged, 80 and over; Antithrombins; Arginine; Brain Ischemia; Female; Fibrinolytic Agents; Humans; Male; Methacrylates; Middle Aged; Pipecolic Acids; Prognosis; Retrospective Studies; Severity of Illness Index; Stroke; Sulfonamides	2018
[Safety of Dual Antiplatelet Therapy with Argatroban in Patients with Acute Ischemic Stroke]. Brain and nerve = Shinkei kenkyu no shinpo, 2018, Volume: 70, Issue:5 Topics: Arginine; Brain Ischemia; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Pipecolic Acids; Platelet Aggregation Inhibitors; Retrospective Studies; Stroke; Sulfonamides	2018
Argatroban plus aspirin versus aspirin in acute ischemic stroke. Neurological research, 2018, Volume: 40, Issue:10 Topics: Arginine; Aspirin; Brain Ischemia; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Pipecolic Acids; Platelet Aggregation Inhibitors; Retrospective Studies; Severity of Illness Index; Statistics as Topic; Stroke; Sulfonamides; Treatment Outcome	2018
Serum asymmetric dimethylarginine and nitric oxide levels in Turkish patients with acute ischemic stroke. Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 2019, Volume: 28, Issue:5 Topics: Aged; Aged, 80 and over; Arginine; Brain Ischemia; Female; Humans; Male; Middle Aged; Nitric Oxide; Stroke	2019
MELAS: Monitoring treatment with magnetic resonance spectroscopy. Acta neurologica Scandinavica, 2019, Volume: 139, Issue:1 Topics: Arginine; Aspartic Acid; Brain; Choline; Female; Humans; Magnetic Resonance Spectroscopy; MELAS Syndrome; Middle Aged; Stroke; Treatment Outcome	2019
L-Arginine prevents stroke-like episodes but not brain atrophy: a 20-year follow-up of a MELAS patient. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2019, Volume: 40, Issue:1 Topics: Adolescent; Adult; Arginine; Atrophy; Brain; Female; Follow-Up Studies; Humans; MELAS Syndrome; Stroke; Young Adult	2019
Safety and Feasibility of Argatroban, Recombinant Tissue Plasminogen Activator, and Intra-Arterial Therapy in Stroke (ARTSS-IA Study). Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2018, Volume: 27, Issue:12 Topics: Aged; Aged, 80 and over; Arginine; Cerebral Hemorrhage; Combined Modality Therapy; Drug Therapy, Combination; Endovascular Procedures; Feasibility Studies; Fibrinolytic Agents; Humans; Incidence; Middle Aged; Pipecolic Acids; Platelet Aggregation Inhibitors; Postoperative Complications; Stroke; Sulfonamides; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome	2018
Guanidino compound ratios are associated with stroke etiology, internal carotid artery stenosis and CHA Journal of the neurological sciences, 2019, 02-15, Volume: 397 Topics: Aged; Arginine; Biomarkers; Brain Ischemia; Carotid Arteries; Carotid Stenosis; Cross-Sectional Studies; Female; Homoarginine; Humans; Intracranial Hemorrhages; Male; Middle Aged; Recurrence; Stroke	2019
L-arginine pathway metabolites can discriminate paroxysmal from permanent atrial fibrillation in acute ischemic stroke. Ideggyogyaszati szemle, 2019, Mar-30, Volume: 72, Issue:3-4 Topics: Arginine; Atrial Fibrillation; Biomarkers; Brain Ischemia; Humans; Stroke	2019
Role of complement 3a in the growth of mesangial cells from stroke-prone spontaneously hypertensive rats. Clinical and experimental hypertension (New York, N.Y. : 1993), 2014, Volume: 36, Issue:1 Topics: Actins; Angiotensin II; Animals; Arginine; Benzhydryl Compounds; Cell Proliferation; Complement C3a; Gene Expression; Hypertension; Kidney Cortex; Male; Mesangial Cells; Myocytes, Smooth Muscle; Osteopontin; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Complement; RNA, Messenger; Stroke	2014
Effects of medullary administration of a nitric oxide precursor on cardiovascular responses and neurotransmission during static exercise following ischemic stroke. Canadian journal of physiology and pharmacology, 2013, Volume: 91, Issue:7 Topics: Animals; Arginine; Cardiovascular System; Female; gamma-Aminobutyric Acid; Glutamic Acid; Infarction, Middle Cerebral Artery; Microdialysis; Muscle Contraction; Muscle, Skeletal; Nitric Oxide; omega-N-Methylarginine; Physical Conditioning, Animal; Rats; Rats, Sprague-Dawley; Reperfusion; Stroke; Synaptic Transmission	2013
Plasma asymmetric dimethylarginine and adverse events in patients with atrial fibrillation referred for coronary angiogram. PloS one, 2013, Volume: 8, Issue:8 Topics: Aged; Aged, 80 and over; Arginine; Atrial Fibrillation; Cardiovascular Diseases; Coronary Angiography; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Multivariate Analysis; Predictive Value of Tests; Proportional Hazards Models; Referral and Consultation; Risk Assessment; Risk Factors; Stroke; Survival Rate; Time Factors	2013
R is for arginine: metabolism of arginine takes off again, in new directions. Circulation, 2013, Sep-24, Volume: 128, Issue:13 Topics: Amidinotransferases; Animals; Arginine; Female; Homoarginine; Humans; Male; Stroke	2013
Homoarginine levels are regulated by L-arginine:glycine amidinotransferase and affect stroke outcome: results from human and murine studies. Circulation, 2013, Sep-24, Volume: 128, Issue:13 Topics: Adult; Aged; Amidinotransferases; Animals; Arginine; Cohort Studies; Disease Models, Animal; Female; Genome-Wide Association Study; HEK293 Cells; Homoarginine; Humans; Male; Mice; Mice, Inbred C57BL; Middle Aged; Polymorphism, Single Nucleotide; Prospective Studies; Stroke; Treatment Outcome	2013
Neuroprotective effects of argatroban and C5a receptor antagonist (PMX53) following intracerebral haemorrhage. Clinical and experimental immunology, 2014, Volume: 175, Issue:2 Topics: Animals; Apoptosis; Arginine; Brain Edema; Cerebral Hemorrhage; Complement C5a; Inflammation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuroprotective Agents; Peptides, Cyclic; Pipecolic Acids; Platelet Aggregation Inhibitors; Receptor, Anaphylatoxin C5a; RNA, Messenger; Stroke; Sulfonamides; Tubulin	2014
Letter by Kurtoglu et al regarding article, "Asymmetric dimethylarginine in response to recombinant tissue-type plasminogen activator and erythropoietin in acute stroke". Stroke, 2013, Volume: 44, Issue:12 Topics: Arginine; Drug Therapy, Combination; Erythropoietin; Female; Humans; Male; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator	2013
Response to letter regarding article, "Asymmetric dimethylarginine in response to recombinant tissue-type plasminogen activator and erythropoietin in acute stroke". Stroke, 2013, Volume: 44, Issue:12 Topics: Arginine; Drug Therapy, Combination; Erythropoietin; Female; Humans; Male; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator	2013
Investigation of effect of edaravone on ischemic stroke. The Kurume medical journal, 2013, Volume: 60, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antipyrine; Arginine; Edaravone; Female; Free Radical Scavengers; Humans; Ischemia; Male; Methacrylates; Middle Aged; Pipecolic Acids; Retrospective Studies; Risk Factors; Stroke; Sulfonamides; Young Adult	2013
Asymmetric dimethylarginine is related to the predicted stroke risk in middle-aged Japanese men. Journal of the neurological sciences, 2014, Mar-15, Volume: 338, Issue:1-2 Topics: Adult; Aged; Arginine; Humans; Linear Models; Male; Middle Aged; Retrospective Studies; Risk Factors; Stroke; Surveys and Questionnaires; Young Adult	2014
The salt stimulation property of serum paraoxonase (PON1) could be a valuable factor in evaluating the enzyme status in ischemic stroke: the role of activity-determined PON1 192Q/R phenotypes. Journal of the neurological sciences, 2014, Mar-15, Volume: 338, Issue:1-2 Topics: Aged; Aged, 80 and over; Arginine; Aryldialkylphosphatase; Female; Genotype; Glutamine; Humans; Male; Middle Aged; Multivariate Analysis; Phenotype; Polymorphism, Single Nucleotide; Sodium Chloride; Spectrophotometry; Statistics as Topic; Stroke; Waist-Hip Ratio	2014
The asymmetric dimethylarginine level is associated with the predicted stroke risk in Japanese women. Journal of atherosclerosis and thrombosis, 2014, Volume: 21, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Arginine; Cross-Sectional Studies; Female; Follow-Up Studies; Humans; Japan; Middle Aged; Odds Ratio; Prognosis; Risk Factors; Stroke	2014
Direct thrombin inhibitor argatroban reduces stroke damage in 2 different models. Stroke, 2014, Volume: 45, Issue:3 Topics: Animals; Arginine; Brain; Brain Ischemia; Learning Curve; Male; Maze Learning; Pipecolic Acids; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Stroke; Sulfonamides; Thrombin	2014
[Determination of the critical time point for efficacy of L-arginine infusion therapy in a case of MELAS with frequent stroke-like episodes]. No to hattatsu = Brain and development, 2014, Volume: 46, Issue:1 Topics: Arginine; Child; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; MELAS Syndrome; Stroke; Time Factors; Treatment Outcome	2014
The L-arginine pathway in acute ischemic stroke and severe carotid stenosis: temporal profiles and association with biomarkers and outcome. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2014, Volume: 23, Issue:8 Topics: Aged; Aged, 80 and over; Arginine; Biomarkers; C-Reactive Protein; Carotid Stenosis; Comorbidity; Female; Humans; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; S100 Calcium Binding Protein beta Subunit; Stroke	2014
Successful catheter ablation decreases platelet activation and improves endothelial function in patients with atrial fibrillation. Heart rhythm, 2014, Volume: 11, Issue:11 Topics: Aged; Arginine; Atrial Fibrillation; Biomarkers; Catheter Ablation; Electrocardiography; Endothelium, Vascular; Female; Follow-Up Studies; Humans; Integrin beta3; Male; Middle Aged; P-Selectin; Platelet Activation; Prospective Studies; Recurrence; Stroke	2014
Genome-wide association study of L-arginine and dimethylarginines reveals novel metabolic pathway for symmetric dimethylarginine. Circulation. Cardiovascular genetics, 2014, Volume: 7, Issue:6 Topics: Adult; Aged; Amidohydrolases; Arginine; Binding Sites; Cohort Studies; Female; Genetic Loci; Genome-Wide Association Study; Genotype; HEK293 Cells; Humans; Male; Mediator Complex; Middle Aged; Polymorphism, Single Nucleotide; Protein Structure, Tertiary; Risk Factors; Stroke; Substrate Specificity; Transaminases	2014
Involvement of Arg306 mutation in factor V gene in two young men with ischemic stroke. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2014, Volume: 25, Issue:8 Topics: Anticholesteremic Agents; Arginine; Aspirin; Brain Ischemia; DNA Mutational Analysis; Factor V; Fibrinolytic Agents; Fluorobenzenes; Humans; Intracranial Thrombosis; Male; Middle Aged; Mutation; Pyrimidines; Rosuvastatin Calcium; Stroke; Sulfonamides; Young Adult	2014
[Case of spontaneous cervical internal carotid artery dissection with embolic stroke after a job-change]. Journal of UOEH, 2014, Dec-01, Volume: 36, Issue:4 Topics: Antipyrine; Arginine; Carotid Artery, Internal, Dissection; Diagnosis, Differential; Edaravone; Humans; Infarction, Middle Cerebral Artery; Intracranial Embolism; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Middle Aged; Personnel Turnover; Pipecolic Acids; Platelet Aggregation Inhibitors; Stress, Psychological; Stroke; Sulfonamides; Workload; Workplace	2014
[The relationship between serum asymmetric dimethylarginine and ABCD2 score in transient ischemic attack patients]. Zhonghua nei ke za zhi, 2014, Volume: 53, Issue:11 Topics: Arginine; Case-Control Studies; Cerebral Infarction; Humans; Ischemic Attack, Transient; Risk Factors; Stroke	2014
Poly-arginine and arginine-rich peptides are neuroprotective in stroke models. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2015, Volume: 35, Issue:6 Topics: Animals; Arginine; Calcium; Cells, Cultured; Disease Models, Animal; Endocytosis; Glutamic Acid; Heparan Sulfate Proteoglycans; Male; Neurons; Neuroprotective Agents; Peptides; Rats, Sprague-Dawley; Stroke	2015
A blinded, randomized study of L-arginine in small clot embolized rabbits. Experimental neurology, 2015, Volume: 266 Topics: Animals; Arginine; Behavior, Animal; Dose-Response Relationship, Drug; Embolization, Therapeutic; Fibrinolytic Agents; Intracranial Embolism; Intracranial Hemorrhages; Male; Neuroprotective Agents; Rabbits; Stroke; Treatment Outcome	2015
Arginase I release from activated neutrophils induces peripheral immunosuppression in a murine model of stroke. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2015, Volume: 35, Issue:10 Topics: Animals; Arginase; Arginine; Immune Tolerance; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Inbred C57BL; Neutrophil Activation; Neutrophils; Spleen; Stroke; T-Lymphocytes	2015
Novel oral anticoagulants and reversal agents: Considerations for clinical development. American heart journal, 2015, Volume: 169, Issue:6 Topics: Administration, Oral; Antibodies, Monoclonal, Humanized; Anticoagulants; Arginine; Cardiovascular Diseases; Factor Xa; Factor Xa Inhibitors; Hemorrhage; Humans; Piperazines; Recombinant Proteins; Stroke	2015
Clinical and radiologic reversal of stroke-like episodes in MELAS with high-dose L-arginine. Neurology, 2015, Jul-14, Volume: 85, Issue:2 Topics: Arginine; Child; Humans; Male; MELAS Syndrome; Stroke	2015
Tissue Kallikrein Activity, Detected by a Novel Method, May Be a Predictor of Recurrent Stroke: A Case-Control Study. Disease markers, 2015, Volume: 2015 Topics: Aged; Arginine; Biomarkers; Case-Control Studies; Female; Humans; Male; Middle Aged; Recurrence; Stroke; Tissue Kallikreins; Urinalysis	2015
Simultaneous stable-isotope dilution GC-MS measurement of homoarginine, guanidinoacetate and their common precursor arginine in plasma and their interrelationships in healthy and diseased humans. Amino acids, 2016, Volume: 48, Issue:3 Topics: Adult; Aged; Arginine; Deuterium; Female; Gas Chromatography-Mass Spectrometry; Glycine; Healthy Volunteers; Homoarginine; Humans; Indicator Dilution Techniques; Ischemia; Isotope Labeling; Male; Middle Aged; Molecular Structure; Racial Groups; Stroke; Young Adult	2016
Outcomes of Argatroban Treatment in Patients With Atherothrombotic Stroke: Observational Nationwide Study in Japan. Stroke, 2016, Volume: 47, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antithrombins; Arginine; Case-Control Studies; Cohort Studies; Female; Hemorrhage; Humans; Intracranial Arteriosclerosis; Intracranial Thrombosis; Japan; Male; Middle Aged; Odds Ratio; Pipecolic Acids; Practice Guidelines as Topic; Retrospective Studies; Stroke; Sulfonamides; Treatment Outcome	2016
ADMA--a Possible Marker for Early Therapeutic Outcome in Acute Stroke. Clinical laboratory, 2015, Volume: 61, Issue:11 Topics: Aged; Arginine; Biomarkers; Female; Humans; Male; Middle Aged; Stroke; Thrombolytic Therapy	2015
[THE CLINICAL LABORATORY MARKERS OF ATHEROSCLEROSIS IN PATIENTS WITH ATHEROTHROMBOTIC STROKE]. Klinicheskaia laboratornaia diagnostika, 2015, Volume: 60, Issue:10 Topics: Aged; Aged, 80 and over; Arginine; Atherosclerosis; Biomarkers; C-Reactive Protein; Carotid Stenosis; Case-Control Studies; Female; Humans; Male; Middle Aged; Phospholipases A2; Pregnancy-Associated Plasma Protein-A; Stroke	2015
Correlation of the L-Arginine Pathway with Thrombo-Inflammation May Contribute to the Outcome of Acute Ischemic Stroke. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2016, Volume: 25, Issue:8 Topics: Aged; Aged, 80 and over; Analysis of Variance; Arginine; Brain Ischemia; Chemokine CCL2; Cytokines; Female; Humans; Inflammation; Male; Middle Aged; P-Selectin; Severity of Illness Index; Signal Transduction; Statistics as Topic; Stroke; Time Factors	2016
L-Arginine intervention at hyper-acute phase protects the prolonged MRI abnormality in MELAS. Journal of neurology, 2016, Volume: 263, Issue:8 Topics: Arginine; Child; Female; Humans; Magnetic Resonance Imaging; MELAS Syndrome; Stroke	2016
The role of L-arginine/L-homoarginine/nitric oxide pathway for aortic distensibility and intima-media thickness in stroke patients. Amino acids, 2017, Volume: 49, Issue:6 Topics: Aorta; Arginine; Atherosclerosis; Endothelium, Vascular; Female; Homoarginine; Humans; Male; Middle Aged; Nitric Oxide; Stroke; Ultrasonography; Vascular Remodeling	2017
High plasma glutamate concentrations are associated with infarct growth in acute ischemic stroke. Neurology, 2008, Dec-02, Volume: 71, Issue:23 Topics: Arginine; Cerebral Infarction; Chi-Square Distribution; Chromatography, High Pressure Liquid; Diffusion Magnetic Resonance Imaging; Female; Glutamic Acid; Humans; Image Processing, Computer-Assisted; Interleukin-6; Linear Models; Male; Retrospective Studies; Stroke; Time Factors; Tumor Necrosis Factor-alpha	2008
Dimethylarginine levels in cerebrospinal fluid of hyperacute ischemic stroke patients are associated with stroke severity. Neurochemical research, 2009, Volume: 34, Issue:9 Topics: Aged; Arginine; Brain Ischemia; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Stroke	2009
Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke. Atherosclerosis, 2010, Volume: 208, Issue:2 Topics: Aged; Aged, 80 and over; Albumins; Arginine; beta-Thromboglobulin; C-Reactive Protein; Endothelium, Vascular; Enzyme Inhibitors; Female; Glomerular Filtration Rate; Humans; Ischemia; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; Risk Factors; Stroke; von Willebrand Factor	2010
Dimethylarginine dimethylaminohydrolase-1 transgenic mice are not protected from ischemic stroke. PloS one, 2009, Oct-07, Volume: 4, Issue:10 Topics: Amidohydrolases; Animals; Arginine; Brain; Endothelium, Vascular; Genotype; Infarction, Middle Cerebral Artery; Ischemia; Male; Mice; Mice, Transgenic; Models, Biological; Nitric Oxide; Stroke	2009
Relation of baseline plasma ADMA levels to cardiovascular morbidity and mortality at two years in men with diabetes mellitus referred for coronary angiography. Atherosclerosis, 2010, Volume: 210, Issue:1 Topics: Aged; Arginine; Coronary Angiography; Coronary Disease; Diabetes Complications; Humans; Male; Myocardial Infarction; Prognosis; Proportional Hazards Models; Stroke	2010
Alterations in the modulation of cerebrovascular tone and blood flow by nitric oxide synthases in SHRsp with stroke. Cardiovascular research, 2010, Apr-01, Volume: 86, Issue:1 Topics: Animals; Arginine; Biopterins; Blood Pressure; Cerebral Hemorrhage; Cerebrovascular Circulation; Enzyme Inhibitors; Homeostasis; Hypertension; Male; Middle Cerebral Artery; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Rats; Rats, Inbred SHR; Stroke; Vasodilation	2010
Asymmetric dimethylarginine (ADMA) as a possible risk marker for ischemic stroke. Journal of the neurological sciences, 2010, Mar-15, Volume: 290, Issue:1-2 Topics: Age Factors; Aged; Arginine; Biomarkers; Blood Glucose; Brain Ischemia; Cholesterol, LDL; Dyslipidemias; Female; Humans; Hypertension; Male; Middle Aged; Nitric Oxide; Predictive Value of Tests; Risk Factors; Sensitivity and Specificity; Stroke; Up-Regulation	2010
A novel loss-of-function DDAH1 promoter polymorphism is associated with increased susceptibility to thrombosis stroke and coronary heart disease. Circulation research, 2010, Apr-02, Volume: 106, Issue:6 Topics: Aged; Amidohydrolases; Arginine; Asian People; Binding Sites; Biomarkers; Case-Control Studies; Cells, Cultured; Chi-Square Distribution; China; Coronary Artery Disease; DNA Mutational Analysis; DNA-Binding Proteins; Female; Gene Expression Regulation, Enzymologic; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Mutagenesis, Insertional; Odds Ratio; Phenotype; Polymorphism, Genetic; Promoter Regions, Genetic; Risk Assessment; Risk Factors; Sequence Deletion; Stroke; Thrombosis; Transcription Factor MTF-1; Transcription Factors; Transcriptional Activation; Transfection	2010
Down but not out: candidate gene-based studies still have value in a world dominated by whole genome approaches. Circulation research, 2010, Apr-02, Volume: 106, Issue:6 Topics: Amidohydrolases; Arginine; Asian People; Biomarkers; China; Coronary Artery Disease; Evidence-Based Medicine; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Phenotype; Polymorphism, Genetic; Promoter Regions, Genetic; Risk Factors; Stroke; Thrombosis	2010
Localized cerebral energy failure in DNA polymerase gamma-associated encephalopathy syndromes. Brain : a journal of neurology, 2010, Volume: 133, Issue:Pt 5 Topics: Arginine; Brain; Brain Diseases; Cerebellum; Cysteine; Diffuse Cerebral Sclerosis of Schilder; Diffusion Magnetic Resonance Imaging; Disease Progression; DNA Polymerase gamma; DNA-Directed DNA Polymerase; DNA, Mitochondrial; Electroencephalography; Energy Metabolism; Epilepsy; Glycine; Humans; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Mitochondrial Diseases; Mutation; Neocortex; Sensitivity and Specificity; Spinocerebellar Ataxias; Stroke; Syndrome; Thalamus; Tomography, X-Ray Computed	2010
L-arginine is effective in stroke-like episodes of MELAS associated with the G13513A mutation. Brain & development, 2011, Volume: 33, Issue:6 Topics: Adolescent; Arginine; Brain; Humans; Male; MELAS Syndrome; Point Mutation; Stroke	2011
Asymmetric dimethylarginine as a risk marker for early-onset ischemic stroke in Indian population. Clinica chimica acta; international journal of clinical chemistry, 2011, Jan-14, Volume: 412, Issue:1-2 Topics: Adolescent; Adult; Analysis of Variance; Arginine; Biomarkers; Brain Ischemia; Case-Control Studies; Female; Humans; India; Linear Models; Male; Middle Aged; Risk; Stroke; Time Factors; Young Adult	2011
Serum pentosidine, an advanced glycation end product, indicates poor outcomes after acute ischemic stroke. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2012, Volume: 21, Issue:5 Topics: Aged; Arginine; Biomarkers; Cohort Studies; Female; Glycation End Products, Advanced; Hospitalization; Humans; Logistic Models; Lysine; Male; Prognosis; Prospective Studies; Risk Assessment; Risk Factors; Stroke	2012
Effect of long-term oral treatment with L-arginine and idebenone on the prevention of stroke-like episodes in an adult MELAS patient. Revue neurologique, 2011, Volume: 167, Issue:11 Topics: Administration, Oral; Adult; Antioxidants; Arginine; Drug Combinations; Female; Humans; MELAS Syndrome; Stroke; Time Factors; Treatment Outcome; Ubiquinone	2011
High plasma dimethylarginine levels are associated with adverse clinical outcome after stroke. Journal of atherosclerosis and thrombosis, 2011, Volume: 18, Issue:9 Topics: Aged; Arginine; Case-Control Studies; Chromatography, High Pressure Liquid; Female; Humans; Male; Middle Aged; Prospective Studies; Reproducibility of Results; Stroke; Tandem Mass Spectrometry	2011
Melatonin treatment following stroke induction modulates L-arginine metabolism. Journal of pineal research, 2011, Volume: 51, Issue:3 Topics: Animals; Arginine; Blotting, Western; Cell Line, Tumor; Disease Models, Animal; Humans; Male; Melatonin; Middle Cerebral Artery; Nitric Oxide Synthase; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Stroke	2011
Asymmetric dimethylarginine and clinical outcomes in chronic kidney disease. Clinical journal of the American Society of Nephrology : CJASN, 2011, Volume: 6, Issue:7 Topics: Aged; Aged, 80 and over; Albuminuria; Arginine; Biomarkers; Chi-Square Distribution; Chromatography, High Pressure Liquid; Disease-Free Survival; Female; Glomerular Filtration Rate; Humans; Kaplan-Meier Estimate; Kidney Diseases; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index; Stroke; Taiwan; Time Factors	2011
Symmetric dimethylarginine is a marker of detrimental outcome in the acute phase after ischaemic stroke: role of renal function. Clinical science (London, England : 1979), 2012, Volume: 122, Issue:3 Topics: Aged; Aged, 80 and over; Arginine; Biomarkers; Brain Ischemia; Chromatography, Liquid; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Kidney; Male; Middle Aged; Multivariate Analysis; Outcome Assessment, Health Care; Prognosis; Proportional Hazards Models; Stroke; Tandem Mass Spectrometry; Time Factors	2012
Increased plasma levels of total homocysteine but not asymmetric dimethylarginine in Hispanic subjects with ischemic stroke FREC-VI sub-study. European journal of neurology, 2012, Volume: 19, Issue:3 Topics: Aged; Arginine; Case-Control Studies; Colombia; Female; Hispanic or Latino; Homocysteine; Humans; Male; Middle Aged; Risk Factors; Stroke	2012
The argatroban and tissue-type plasminogen activator stroke study: final results of a pilot safety study. Stroke, 2012, Volume: 43, Issue:3 Topics: Aged; Anticoagulants; Antithrombins; Arginine; Brain Ischemia; Cerebral Arteries; Cerebral Hemorrhage; Cerebral Veins; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Partial Thromboplastin Time; Pilot Projects; Pipecolic Acids; Stroke; Sulfonamides; Tissue Plasminogen Activator; Treatment Outcome; Ultrasonography, Doppler, Transcranial	2012
The argatroban and tissue-type plasminogen activator stroke study: final results of a pilot safety study. Stroke, 2012, Volume: 43, Issue:3 Topics: Anticoagulants; Antithrombins; Arginine; Female; Humans; Male; Pipecolic Acids; Stroke; Sulfonamides; Tissue Plasminogen Activator	2012
Effect of atrial fibrillation on atrial thrombogenesis in humans: impact of rate and rhythm. Journal of the American College of Cardiology, 2013, Feb-26, Volume: 61, Issue:8 Topics: Aged; Antithrombin III; Arginine; Atrial Fibrillation; Catheter Ablation; CD40 Ligand; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Female; Heart Atria; Heart Rate; Humans; Male; Middle Aged; P-Selectin; Peptide Hydrolases; Platelet Activation; Risk Assessment; Risk Factors; Statistics as Topic; Stroke; Thrombosis	2013
C455R notch3 mutation in a Colombian CADASIL kindred with early onset of stroke. Neurology, 2002, Jul-23, Volume: 59, Issue:2 Topics: Adult; Age of Onset; Aged; Arginine; Colombia; Cysteine; Dementia, Multi-Infarct; DNA Mutational Analysis; Female; Heterozygote; Humans; Male; Middle Aged; Mutation; Stroke	2002
Endothelium-dependent relaxation in pulmonary arteries of L-NAME-treated Wistar and stroke-prone spontaneously hypertensive rats. Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi, 2002, Volume: 38, Issue:4-5 Topics: Animals; Arginine; Blood Pressure; Body Weight; Cardiovascular Agents; Endothelium, Vascular; Enzyme Inhibitors; Genetic Predisposition to Disease; Hypertension; Indomethacin; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Donors; Nitroarginine; Nitroprusside; Pulmonary Artery; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Wistar; Stroke; Vasodilation	2002
L-arginine levels in blood as a marker of nitric oxide-mediated brain damage in acute stroke: a clinical and experimental study. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2003, Volume: 23, Issue:8 Topics: Acute Disease; Aged; Animals; Arginine; Biomarkers; Brain Abscess; Chromatography, Liquid; Female; Humans; Male; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Inbred F344; Stroke	2003
Hyperhomocysteinemia, oxidative stress, and cerebral vascular dysfunction. Stroke, 2004, Volume: 35, Issue:2 Topics: Arginine; Cerebrovascular Circulation; DNA Methylation; Homocysteine; Humans; Hyperhomocysteinemia; Oxidative Stress; Reactive Oxygen Species; Risk Factors; Stroke	2004
The combined effect of paraoxonase promoter and coding region polymorphisms on the risk of arterial ischemic stroke among young adults. Archives of neurology, 2004, Volume: 61, Issue:3 Topics: Adult; Arginine; Aryldialkylphosphatase; Case-Control Studies; Confidence Intervals; Demography; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Glutamine; Humans; Logistic Models; Male; Odds Ratio; Open Reading Frames; Polymerase Chain Reaction; Polymorphism, Genetic; Promoter Regions, Genetic; Risk; Sequence Analysis, DNA; Stroke	2004
Homocysteine, vitamin B6, and endothelial dysfunction in circulatory disorders. Stroke, 2004, Volume: 35, Issue:8 Topics: Arginine; C-Reactive Protein; Endothelium, Vascular; Homocysteine; Humans; Nitric Oxide; Pyridoxal Phosphate; Stroke; Vitamin B 6; Vitamin B 6 Deficiency	2004
Acute ischemic stroke successfully treated using sequenced intravenous and intra-arterial thrombolysis and argatroban anticoagulation: a case study. Journal of thrombosis and thrombolysis, 2004, Volume: 17, Issue:2 Topics: Acute Disease; Adult; Anticoagulants; Arginine; Brain Ischemia; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Pipecolic Acids; Stroke; Sulfonamides	2004
Beneficial effect of L-arginine for stroke-like episode in MELAS. Brain & development, 2004, Volume: 26, Issue:7 Topics: Adolescent; Arginine; Brain; Brain Ischemia; Drug Therapy, Combination; Energy Metabolism; Female; Glycerol; Humans; Lactic Acid; MELAS Syndrome; Mitochondria; Nitric Oxide; Prednisolone; Seizures; Stroke; Treatment Outcome; Vasodilator Agents; Vision Disorders	2004
Nutritional prevention on hypertension, cerebral hemodynamics and thrombosis in stroke-prone spontaneously hypertensive rats. Cellular and molecular neurobiology, 2004, Volume: 24, Issue:5 Topics: Animal Feed; Animals; Antioxidants; Arginine; Blood Flow Velocity; Cerebrovascular Circulation; Intracranial Thrombosis; Nutritional Physiological Phenomena; Pia Mater; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Stroke	2004
Reduction of Gstm1 expression in the stroke-prone spontaneously hypertension rat contributes to increased oxidative stress. Hypertension (Dallas, Tex. : 1979), 2005, Volume: 45, Issue:4 Topics: Amino Acid Sequence; Animals; Aorta; Arginine; Blotting, Western; Computer Systems; Genetic Predisposition to Disease; Glutathione Transferase; Histidine; Hypertension; Immunohistochemistry; Kidney; Molecular Sequence Data; Oxidative Stress; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Stroke; Superoxides	2005
Asymmetric dimethylarginine (ADMA) as a risk marker for stroke and TIA in a Swedish population. Atherosclerosis, 2006, Volume: 185, Issue:2 Topics: Acute Disease; Aged; Arginine; Biomarkers; Cerebral Hemorrhage; Cerebral Infarction; Enzyme Inhibitors; Female; Glycated Hemoglobin; Humans; Ischemic Attack, Transient; Male; Multivariate Analysis; Nitric Oxide Synthase; Odds Ratio; Risk Factors; Stroke	2006
Evaluation of the paraoxonases as candidate genes for stroke: Gln192Arg polymorphism in the paraoxonase 1 gene is associated with increased risk of stroke. Stroke, 2005, Volume: 36, Issue:11 Topics: Arginine; Aryldialkylphosphatase; Female; Gene Expression Regulation; Genetic Predisposition to Disease; Genotype; Glutamine; Heterozygote; Homozygote; Humans; Lipoproteins, LDL; Male; Multivariate Analysis; Odds Ratio; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Pravastatin; Risk; Risk Factors; Stroke	2005
PON1 55/192 polymorphism, oxidative stress, type, prognosis and severity of stroke. IUBMB life, 2006, Volume: 58, Issue:3 Topics: Aged; Amino Acid Substitution; Arginine; Aryldialkylphosphatase; Female; Glutamine; Humans; Leucine; Male; Methionine; Oxidative Stress; Polymorphism, Genetic; Prognosis; Risk Factors; Severity of Illness Index; Stroke	2006
Statins and cerebral vasomotor reactivity: implications for a new therapy? Stroke, 2006, Volume: 37, Issue:10 Topics: Adult; Animals; Arginine; Atorvastatin; Brain Ischemia; Cerebrovascular Circulation; Clinical Trials, Phase II as Topic; Endothelium, Vascular; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Intracranial Aneurysm; Mice; Middle Cerebral Artery; Nitric Oxide; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Research Design; Risk Factors; Simvastatin; Stroke; Subarachnoid Hemorrhage; Ultrasonography, Doppler, Transcranial; Vasodilation; Vasomotor System; Vasospasm, Intracranial	2006
Effect of chlorella and its fractions on blood pressure, cerebral stroke lesions, and life-span in stroke-prone spontaneously hypertensive rats. Journal of nutritional science and vitaminology, 2006, Volume: 52, Issue:6 Topics: Analysis of Variance; Animals; Antioxidants; Arginine; Blood Coagulation Tests; Blood Pressure; Body Weight; Brain Chemistry; Carotenoids; Chlorella; Cholesterol; Dietary Supplements; Hypertension; Male; Organ Size; Phospholipids; Plant Extracts; Rats; Rats, Inbred SHR; Stroke; Survival Rate; Time Factors	2006
Efficacy of anti-coagulant treatment with argatroban on cardioembolic stroke. Journal of neurology, 2007, Volume: 254, Issue:5 Topics: Aged; Aged, 80 and over; Anticoagulants; Arginine; Cohort Studies; Female; Heparin; Humans; Japan; Male; Pipecolic Acids; Registries; Regression Analysis; Retrospective Studies; Severity of Illness Index; Stroke; Sulfonamides	2007
Effects of long-term administration of HMG-CoA reductase inhibitor, atorvastatin, on stroke events and local cerebral blood flow in stroke-prone spontaneously hypertensive rats. Brain research, 2007, Sep-12, Volume: 1169 Topics: Animals; Arginine; Atorvastatin; Brain; Cerebral Arteries; Cerebrovascular Circulation; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Endothelial Cells; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Lipid Metabolism; Male; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Synthase; Pyrroles; Rats; Rats, Inbred SHR; Stroke; Survival Rate; Time; Time Factors; Treatment Outcome	2007
Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke. Clinical biochemistry, 2008, Volume: 41, Issue:1-2 Topics: Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Arginine; Aryldialkylphosphatase; Carboxylic Ester Hydrolases; Case-Control Studies; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Glutamine; Humans; Hypoxia-Ischemia, Brain; Male; Middle Aged; Polymorphism, Genetic; Risk; Stroke	2008
Asymmetric dimethylarginine independently predicts fatal and nonfatal myocardial infarction and stroke in women: 24-year follow-up of the population study of women in Gothenburg. Arteriosclerosis, thrombosis, and vascular biology, 2008, Volume: 28, Issue:5 Topics: Adult; Arginine; Biomarkers; Cohort Studies; Female; Follow-Up Studies; Homocysteine; Humans; Longitudinal Studies; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Factors; Stroke; Sweden	2008
Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke. Atherosclerosis, 2001, Volume: 158, Issue:2 Topics: Aged; Aged, 80 and over; Arginine; Cerebral Infarction; Chromatography, High Pressure Liquid; Enzyme Inhibitors; Female; Homocysteine; Humans; Logistic Models; Male; Nitric Oxide Synthase; Recurrence; Risk Factors; Stroke	2001
Extension of the therapeutic window for recombinant tissue plasminogen activator with argatroban in a rat model of embolic stroke. Stroke, 2001, Volume: 32, Issue:11 Topics: Animals; Antithrombins; Arginine; Brain Ischemia; Cerebral Hemorrhage; Dose-Response Relationship, Drug; Fibrin; Incidence; Infarction, Middle Cerebral Artery; Intracranial Embolism; Male; Pipecolic Acids; Rats; Rats, Wistar; Recombinant Proteins; Stroke; Sulfonamides; Time Factors; Tissue Plasminogen Activator	2001
Effects of L-arginine on the acute phase of strokes in three patients with MELAS. Neurology, 2002, Mar-12, Volume: 58, Issue:5 Topics: Acute Disease; Adolescent; Arginine; Female; Humans; Male; MELAS Syndrome; Stroke	2002
Neuropeptide Y-Y1 receptor modulates nitric oxide level during stroke in the rat. Free radical biology & medicine, 2002, Apr-15, Volume: 32, Issue:8 Topics: Animals; Arginine; Brain; Electron Spin Resonance Spectroscopy; Injections, Intra-Arterial; Injections, Intraventricular; Male; Neuropeptide Y; Nitric Oxide; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Stroke	2002